In RA-DLBCL patients that received active lymphoma treatment, high expression of PD-L1 in tumor cells was associated with inferior OS in multivariable analysis, whereas high expression of PD-1 in TILs was associated with superior OS in univariate analysis. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.